The Bioabsorbables/Bioresorbables Center

Filter Your Results

 

News

 

Q3 Medical Financing Agreement to Support Product Development and Commercialization

March 15, 2017 -- Q3 Medical Devices Limited announced that it has entered into an €28.3-million investment agreement with Boill Holding Group of Shanghai, China. Th…

Biosensors’ LEADERS FREE II BioFreedom Pivotal Study Begins Enrollment

February 15, 2017 -- Biosensors International Group, Ltd. announced that it has started enrollment in the new BioFreedom pivotal study, called LEADERS FREE II. The study …

Implantation Technique for Bioresorbable Scaffolds

Jiang Ming Fam, MD, MBBS; and Robert-Jan van Geuns, MD

January/February 2017—Device description and patient/lesion selection with the Absorb BVS.

Abbott Vascular's Absorb BVS Studied in Patients With Diabetes Mellitus

January 13, 2017 -- Findings from the Absorb Diabetic Substudy of Abbott Vascular's Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) were published by Dean …

Bioresorbable Vascular Scaffolds Studied for Very Late Scaffold Thrombosis

January 13, 2017 -- Toshiaki Toyota, MD, et al conducted a study that sought to compare the 2-year outcomes between bioresorbable vascular scaffolds (BVS) and metallic everoli…

Retrospective Analysis Evaluates Bioresorbable Vascular Scaffolds to Treat CTOs

January 9, 2017 -- Bioresorbable vascular scaffolds (BVS) are a feasible and safe treatment of chronic total occlusions (CTO), concluded Satoru Mitomo, MD, et al in a study pu…

Abbott Vascular's Absorb Bioresorbable Vascular Scaffold Approved in Japan

November 7, 2016 -- Abbott Vascular announced Japan’s Ministry of Health, Labor, and Welfare has approved the company’s Absorb bioresorbable coronary stent. Sold c…

PRISON IV Trial Evaluates Biotronik’s Osiro Biodegradable SES to Treat CTOs

November 2, 2016 -- The randomized multicenter PRISON IV trial evaluated Biotronik’s hybrid, ultra-thin strut Osiro sirolimus-eluting stent (SES) with a biodeg…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.